171 related articles for article (PubMed ID: 34023209)
1. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.
Coltoff A; Bomback A; Shirazian S; Lentzsch S; Bhutani D
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e674-e677. PubMed ID: 34023209
[No Abstract] [Full Text] [Related]
2. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
[TBL] [Abstract][Full Text] [Related]
3. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
Ravindran A; Fervenza FC; Smith RJH; Sethi S
Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits.
Zand L; Rajkumar SV; Leung N; Sethi S; El Ters M; Fervenza FC
J Am Soc Nephrol; 2021 May; 32(5):1163-1173. PubMed ID: 33685975
[TBL] [Abstract][Full Text] [Related]
5. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
6. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?
Ciocchini M; Musso CG
Int Urol Nephrol; 2018 Jul; 50(7):1365-1366. PubMed ID: 29808447
[No Abstract] [Full Text] [Related]
7. Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance.
Kastritis E; Theodorakakou F; Roussou M; Psimenou E; Gakiopoulou C; Marinaki S; Gatou A; Fotiou D; Migkou M; Kanellias N; Eleutherakis-Papaiakovou E; Malandrakis P; Dialoupi I; Ntanasis-Stathopoulos I; Kostopoulos IV; Terpos E; Gavriatopoulou M; Dimopoulos MA
Br J Haematol; 2021 Apr; 193(1):113-118. PubMed ID: 32829529
[TBL] [Abstract][Full Text] [Related]
8. Pathology after eculizumab in dense deposit disease and C3 GN.
Herlitz LC; Bomback AS; Markowitz GS; Stokes MB; Smith RN; Colvin RB; Appel GB; D'Agati VD
J Am Soc Nephrol; 2012 Jul; 23(7):1229-37. PubMed ID: 22677550
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammopathy of renal significance and membranoproliferative glomerulonephritis: a complex relationship with promising therapeutic opportunities].
Manes M; Radin E; Pellu' V; Molino A A; Gabrielli D; Parodi E; Caputo D; Paternoster G; Barreca A; Pagliaro M; Quattrocchio G; Roccatello D
G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373468
[TBL] [Abstract][Full Text] [Related]
11. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Ann Hematol; 2020 Apr; 99(4):703-714. PubMed ID: 32103323
[TBL] [Abstract][Full Text] [Related]
12. Membranoproliferative glomerulonephritis associated with IgA-λ monoclonal gammopathy.
Wu B; Chen P; Wang W; Li F; Zou S; Cheng Y
Ann Hematol; 2014 Feb; 93(2):359-60. PubMed ID: 23778994
[No Abstract] [Full Text] [Related]
13. Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.
Sathick IJ; Zand L; Nasr SH; Leung N
Clin Nephrol; 2019 Feb; 91(2):79-86. PubMed ID: 30474593
[TBL] [Abstract][Full Text] [Related]
14. Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases.
Hill PA; Firkin F; Dwyer KM; Lee P; Murphy BF
Pathology; 2002 Apr; 34(2):138-43. PubMed ID: 12009095
[TBL] [Abstract][Full Text] [Related]
15. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.
Chauvet S; Frémeaux-Bacchi V; Petitprez F; Karras A; Daniel L; Burtey S; Choukroun G; Delmas Y; Guerrot D; François A; Le Quintrec M; Javaugue V; Ribes D; Vrigneaud L; Arnulf B; Goujon JM; Ronco P; Touchard G; Bridoux F
Blood; 2017 Mar; 129(11):1437-1447. PubMed ID: 28069603
[TBL] [Abstract][Full Text] [Related]
16. Proliferative Glomerulonephritis With Fibrils, Monoclonal κ Light Chain, and C3 Deposits.
Steinberg AG; Fox LC; Bender S; Batrouney A; Juneja S; Sirac C; Touchard G; Blombery P; Finlay MJ; Bridoux F; Barbour TD
Am J Kidney Dis; 2021 Sep; 78(3):459-463. PubMed ID: 33774080
[TBL] [Abstract][Full Text] [Related]
17. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies.
Caravaca-Fontán F; Lucientes L; Serra N; Cavero T; Rodado R; Ramos N; Gonzalez F; Shabaka A; Cabello V; Huerta A; Pampa-Saico S; Gutiérrez E; Quintana LF; López-Rubio ME; Draibe J; Alonso Titos J; Fernández-Juárez G; Goicoechea de Jorge E; Praga M
Nephrol Dial Transplant; 2022 Oct; 37(11):2128-2137. PubMed ID: 34677610
[TBL] [Abstract][Full Text] [Related]
18. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
[TBL] [Abstract][Full Text] [Related]
19. Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.
Serra N; Facundo C; Canal C; Arce Y; Ayasreh N; Vila A; Bardají B; Silva I; López V; Benito S; Ballarín J; Guirado L
Nefrologia (Engl Ed); 2019; 39(2):198-201. PubMed ID: 29914760
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
.
Lepori N; Cheungpasitporn W; Sethi S; Murray D; Kumar S; Leung N; Giridhar KV; Fervenza FC
Clin Nephrol; 2018 Apr; 89(4):291-299. PubMed ID: 29249234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
